BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 3806172)

  • 1. Treatment of hepatosplenic candidiasis with liposomal-amphotericin B.
    Lopez-Berestein G; Bodey GP; Frankel LS; Mehta K
    J Clin Oncol; 1987 Feb; 5(2):310-7. PubMed ID: 3806172
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatosplenic fungal infection: CT and pathologic evaluation after treatment with liposomal amphotericin B.
    Shirkhoda A; Lopez-Berestein G; Holbert JM; Luna MA
    Radiology; 1986 May; 159(2):349-53. PubMed ID: 3961167
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Successful treatment of hepatosplenic candidiasis with a liposomal amphotericin B preparation.
    Björkholm M; Kållberg N; Grimfors G; Eklund LH; Eksborg S; Juneskans OT; Udén AM
    J Intern Med; 1991 Aug; 230(2):173-7. PubMed ID: 1865169
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Liposomal amphotericin B for the treatment of systemic fungal infections in patients with cancer: a preliminary study.
    Lopez-Berestein G; Fainstein V; Hopfer R; Mehta K; Sullivan MP; Keating M; Rosenblum MG; Mehta R; Luna M; Hersh EM
    J Infect Dis; 1985 Apr; 151(4):704-10. PubMed ID: 3973417
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Successful peritransplant therapy in children with active hepatosplenic candidiasis.
    Katayama K; Koizumi S; Yamagami M; Tamaru Y; Ichihara T; Konishi M; Maekawa S; Seki H; Taniguchi N
    Int J Hematol; 1994 Feb; 59(2):125-30. PubMed ID: 8018905
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatosplenic candidiasis in patients with acute leukemia: increasingly encountered complication.
    Sallah S
    Anticancer Res; 1999; 19(1B):757-60. PubMed ID: 10216488
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chronic systemic (hepatosplenic) candidiasis in a patient with granulocytic sarcoma.
    Gangadharan VP; Sasidharan K; Preetha S; Chithrathara K
    Am J Clin Oncol; 2000 Dec; 23(6):562-3. PubMed ID: 11202796
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Treatment of hepatosplenic candidiasis with liposomal amphotericin B in a patient with acute leukemia; a case report of the experience of use of liposomal amphotericin B].
    Hasegawa T; Hiyoshi M; Aoyama Y; Sakamoto C; Ohta K; Yamane T; Hino M; Tatsumi N
    Kansenshogaku Zasshi; 1998 Jun; 72(6):635-7. PubMed ID: 9695475
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatosplenic candidiasis: successful treatment with fluconazole.
    Kauffman CA; Bradley SF; Ross SC; Weber DR
    Am J Med; 1991 Aug; 91(2):137-41. PubMed ID: 1867239
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Liposomal amphotericin B in hepatic candidosis.
    Sharland M; Hay RJ; Davies EG
    Arch Dis Child; 1994 Jun; 70(6):546-7. PubMed ID: 8048832
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatosplenic candidiasis in children with acute leukemia.
    Verdeguer A; Fernández JM; Esquembre C; Ferris J; Ruiz JG; Castel V
    Cancer; 1990 Feb; 65(4):874-7. PubMed ID: 2297657
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fluconazole in the treatment of hepatosplenic candidiasis.
    Flannery MT; Simmons DB; Saba H; Altus P; Wallach PM; Adelman HM
    Arch Intern Med; 1992 Feb; 152(2):406-8. PubMed ID: 1739374
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fluconazole therapy for chronic disseminated candidiasis in patients with leukemia and prior amphotericin B therapy.
    Anaissie E; Bodey GP; Kantarjian H; David C; Barnett K; Bow E; Defelice R; Downs N; File T; Karam G
    Am J Med; 1991 Aug; 91(2):142-50. PubMed ID: 1867240
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ultra-long amphotericin B therapy for hepatosplenic candidiasis complicating acute promyelocytic leukaemia.
    Lai ST; Yeung YM
    Clin Lab Haematol; 1996 Mar; 18(1):62-3. PubMed ID: 9118611
    [No Abstract]   [Full Text] [Related]  

  • 15. Treatment of invasive Aspergillus sinusitis with liposomal-amphotericin B.
    Weber RS; Lopez-Berestein G
    Laryngoscope; 1987 Aug; 97(8 Pt 1):937-41. PubMed ID: 3613794
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatosplenic candidiasis, a fatal disease?
    Loeliger A; van Leeuwen M; Rozenberg-Arska M; Dekker AW
    Infection; 1992; 20(6):336-8. PubMed ID: 1293053
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatosplenic candidiasis in patients with acute leukemia: incidence and prognostic implications.
    Anttila VJ; Elonen E; Nordling S; Sivonen A; Ruutu T; Ruutu P
    Clin Infect Dis; 1997 Mar; 24(3):375-80. PubMed ID: 9114188
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Amphotericin-resistant invasive hepatosplenic candidiasis controlled by fluconazole.
    Jakab K; Kelemen E; Prinz G; Török I
    Lancet; 1990 Feb; 335(8687):473-4. PubMed ID: 1968194
    [No Abstract]   [Full Text] [Related]  

  • 19. Amphotericin B lipid complex for the treatment of patients with acute leukemia and hepatosplenic candidiasis.
    Sallah S; Semelka RC; Sallah W; Vainright JR; Philips DL
    Leuk Res; 1999 Nov; 23(11):995-9. PubMed ID: 10576503
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatosplenic candidiasis after neutropenic phase of acute leukaemia.
    Colović M; Lazarević V; Colović R; Janković G; Suvajdzić N; Bogdanović A; Bila J
    Med Oncol; 1999 Jul; 16(2):139-42. PubMed ID: 10456663
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.